Juan Rapadas, PHD | |
144 Aspinall Ave., Unit 201, Hagatna, GU 96910 | |
(671) 477-3311 | |
Not Available |
Full Name | Juan Rapadas |
---|---|
Gender | Male |
Speciality | Psychologist - Clinical |
Location | 144 Aspinall Ave., Hagatna, Guam |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1598203077 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Juan Rapadas, PHD 144 Aspinall Ave., Unit 201, Hagatna, GU 96910 Ph: (671) 477-3311 | Juan Rapadas, PHD 144 Aspinall Ave., Unit 201, Hagatna, GU 96910 Ph: (671) 477-3311 |
News Archive
A new study from researchers at the Perelman School of Medicine at the University of Pennsylvania and collaborators at various institutions, presented at the 2011 American Heart Association Scientific Sessions, shows that a novel, non-invasive measurement of arterial wave reflections may be able to predict who is most at risk for heart failure.
An estimated 33,000 of the total 5.5 million workers in Vietnam's fishery sector, or about 0.59%, were living with HIV in 2008, according to a survey released Tuesday by Vietnam's fishery program, VNA/VOV News reports (VNA/VOV News, 5/27).
Roche today announced that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for use of Tarceva(R) (erlotinib) as a maintenance therapy for people with advanced non-small cell lung cancer (NSCLC) and stable disease (cancer remains largely unchanged) after initial chemotherapy. The CHMP positive opinion clears the way for European Union approval and means that this group of patients may soon be able to benefit from earlier treatment with Tarceva.
An unexpected discovery by UCLA life scientists holds promise for the future development of treatments for post-traumatic stress disorder and other anxiety disorders, and potentially for Alzheimer's disease and other memory-impairment diseases.
› Verified 2 days ago